Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes: A randomized clinical study

Diabetes Care

Volumn 22, Issue 10, 1999, Pages 1703-1707

  Allen, Holley F ^a   Klingensmith, Georgeanna J ^b   Jensen, Paul ^b   Simoes, Eric ^b   Hayward, Anthony ^b   Chase, H Peter ^b  

^a BAYSTATE MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; C PEPTIDE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE ACTIVATION; BCG VACCINATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTRADERMAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PEPTIDE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REMISSION;

ADOLESCENT; AUTOANTIBODIES; BCG VACCINE; BLOOD GLUCOSE; C-PEPTIDE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DOUBLE-BLIND METHOD; EATING; FEMALE; FOLLOW-UP STUDIES; GLUTAMATE DECARBOXYLASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN ANTIBODIES; ISLETS OF LANGERHANS; MALE; PLACEBOS;

EID: 0032883253     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.10.1703     Document Type: Article

References (15)

1. Assan R, Feutren G, Sirmai J: Cyclosporine trials in diabetes: updated results of the French experience. Transplan Proc 20: 178-183, 1988
2. Sadelain MWJ, Qin H, Sumoski W, Parfrey N, Singh B, Rabinovitch A: Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant. J Autoimmun 3:671-680, 1990
3. McInerney MF, Pek SB, Thomas DW: Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice. Diabetes 40:715-725, 1991
4. Harada M, Kishimoto Y, Makino S: Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res Clin Pract 8:85-89, 1990
5. Shehadeh NN, Laferty KJ: The role of T-cells in the development of autoimmune diabetes. Diabetes Rev 1:141-151, 1993
6. Shehadeh N, Calcinaro F, Bradley BJ, Bruchlim I, Vardi P, Lafferty KJ: Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet 343:706-707, 1994
7. Vardi P, Dib SA, Tuttleman M, Connelly JE, Grinbergs M, Rabizadeh A, Riley WJ, Maclaren NK, Eisenbarth GS, Soeldner JS: Competitive insulin autoantibody assay: prospective evaluation of subjects at high risk for development of type 1 diabetes mellitus. Diabetes 36:1286-1291, 1987
8. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lernmark A: A novel radiobinding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37:344-350, 1994
9. Stiller CR, Dupree J, Gent M, Jenner MR, Keown PA, Laupacis A, Martell R, Rodger NW vonGraffenried B, Wolfe BMJ: Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 223:1362-1367, 1984
10. Pozzilli P, IMDIAB Group: BCG vaccine in insulin-dependent diabetes mellitus. Lancet 349:1520-1521, 1997
11. Vazeou A, Lafferty K, Pergantou E, Spanos E, Gazda L, Bartsocas C: BCG vaccine modulates autoimmune process in newly diagnosed IDDM patients (Preliminary report) (Abstract). Horm Res 84:A26, 1997
12. Elliott JF, Marlin KL, Couch RM: Effect of Bacille Calmette-Guerin vaccination on C-peptide secretion in children newly diagnosed with IDDM. Diabetes Care 21:1691-1693, 1998
13. Dahlquist G, Gothefors L: The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination. Diabetologia 38:873-874, 1995
14. Parent M, Siemiatycki J, Menzies R, Fritschi L, Colle E: Bacille Calmette-Guerin vaccination and incidence of IDDM in Montreal, Canada. Diabetes Care 20:767-772, 1997
15. Singh B, Qin HY: BCG vaccination prevents IDDM progression after disease induction within a narrow window of opportunity (Abstract). Autoimmunity 24:A129, 1996